查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420990

青光眼治疗市场[产品类型：前列腺素类似物(PGA)、α 激动剂、β 受体阻断剂、胆碱能、碳酸酐酶抑制剂、合併用药] - 全球产业分析、规模、份额、成长、趋势与预测，2023-2031 年

Glaucoma Treatment Market [Product Type: Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, Combined Medications] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

青光眼治疗市场 - 报告范围

TMR 关于全球青光眼治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球青光眼治疗市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球青光眼治疗市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解青光眼治疗市场。

市场概况
2023年市场价值 63 亿美元
2031 年市场价值 91 亿美元
CAGR 4.3%

该报告深入探讨了全球青光眼治疗市场的竞争格局。全球青光眼治疗市场的主要参与者已经确定，并且每位参与者都根据不同的属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球青光眼治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2023-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2023-2031
    • 前列腺素类似物 (PGA)
    • α激动剂
    • β受体阻断剂
    • 胆碱能
    • 碳酸酐酶抑制剂
    • 联合用药
  • 市场吸引力分析：按产品类型

第 7 章：全球市场分析与预测：依指标分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依指标划分，2023-2031
    • 闭角型青光眼 (ACG)
    • 开角型青光眼 (OAG)
    • 继发性青光眼
    • 先天性青光眼
    • 其他适应症
  • 市场吸引力分析：依指标分类

第 8 章：全球市场分析与预测：按销售管道

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按销售管道，2023-2031
    • 医院药房
    • 零售药局
    • 网上销售
  • 市场吸引力分析：按销售管道

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2023-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Novartis AG
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Bausch & Lomb Inc.
    • Allergan Plc
    • Perrigo Plc
    • Teva Pharmaceutical Industries Ltd.
    • Akorn, Inc.
    • Mobius Therapeutics, LLC
Product Code: TMRGL16451

Glaucoma Treatment Market - Scope of Report

TMR's report on the global glaucoma treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global glaucoma treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global glaucoma treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the glaucoma treatment market.

Market Snapshot
Market Value in 2023US$ 6.3 Bn
Market Value in 2031US$ 9.1 Bn
CAGR4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global glaucoma treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global glaucoma treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global glaucoma treatment market.

The report delves into the competitive landscape of the global glaucoma treatment market. Key players operating in the global glaucoma treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global glaucoma treatment market profiled in this report.

Key Questions Answered in Global glaucoma treatment Market Report:

  • What is the sales/revenue generated by glaucoma treatment across all regions during the forecast period?
  • What are the opportunities in the global glaucoma treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Glaucoma Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global glaucoma treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global glaucoma treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global glaucoma treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Glaucoma Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Glaucoma Treatment Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Glaucoma Treatment Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2023-2031
    • 6.3.1. Prostaglandin Analogs (PGAs)
    • 6.3.2. Alpha Agonist
    • 6.3.3. Beta Blockers
    • 6.3.4. Cholinergic
    • 6.3.5. Carbonic Anhydrase Inhibitors
    • 6.3.6. Combined Medications
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Glaucoma Treatment Market Analysis and Forecast, by Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication, 2023-2031
    • 7.3.1. Angle Closure Glaucoma (ACG)
    • 7.3.2. Open Angle Glaucoma (OAG)
    • 7.3.3. Secondary Glaucoma
    • 7.3.4. Congenital Glaucoma
    • 7.3.5. Other Indications
  • 7.4. Market Attractiveness Analysis, by Indication

8. Global Glaucoma Treatment Market Analysis and Forecast, by Sales Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Sales Channel, 2023-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Sales
  • 8.4. Market Attractiveness Analysis, by Sales Channel

9. Global Glaucoma Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Glaucoma Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2023-2031
    • 10.3.1. Prostaglandin Analogs (PGAs)
    • 10.3.2. Alpha Agonist
    • 10.3.3. Beta Blockers
    • 10.3.4. Cholinergic
    • 10.3.5. Carbonic Anhydrase Inhibitors
    • 10.3.6. Combined Medications
  • 10.4. Market Value Forecast, by Indication, 2023-2031
    • 10.4.1. Angle Closure Glaucoma (ACG)
    • 10.4.2. Open Angle Glaucoma (OAG)
    • 10.4.3. Secondary Glaucoma
    • 10.4.4. Congenital Glaucoma
    • 10.4.5. Other Indications
  • 10.5. Market Value Forecast, by Sales Channel, 2023-2031
    • 10.5.1. Hospital Pharmacies
    • 10.5.2. Retail Pharmacies
    • 10.5.3. Online Sales
  • 10.6. Market Value Forecast, by Country, 2023-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Indication
    • 10.7.3. By Sales Channel
    • 10.7.4. By Country

11. Europe Glaucoma Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2023-2031
    • 11.3.1. Prostaglandin Analogs (PGAs)
    • 11.3.2. Alpha Agonist
    • 11.3.3. Beta Blockers
    • 11.3.4. Cholinergic
    • 11.3.5. Carbonic Anhydrase Inhibitors
    • 11.3.6. Combined Medications
  • 11.4. Market Value Forecast, by Indication, 2023-2031
    • 11.4.1. Angle Closure Glaucoma (ACG)
    • 11.4.2. Open Angle Glaucoma (OAG)
    • 11.4.3. Secondary Glaucoma
    • 11.4.4. Congenital Glaucoma
    • 11.4.5. Other Indications
  • 11.5. Market Value Forecast, by Sales Channel, 2023-2031
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Sales
  • 11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Indication
    • 11.7.3. By Sales Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Glaucoma Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2023-2031
    • 12.3.1. Prostaglandin Analogs (PGAs)
    • 12.3.2. Alpha Agonist
    • 12.3.3. Beta Blockers
    • 12.3.4. Cholinergic
    • 12.3.5. Carbonic Anhydrase Inhibitors
    • 12.3.6. Combined Medications
  • 12.4. Market Value Forecast, by Indication, 2023-2031
    • 12.4.1. Angle Closure Glaucoma (ACG)
    • 12.4.2. Open Angle Glaucoma (OAG)
    • 12.4.3. Secondary Glaucoma
    • 12.4.4. Congenital Glaucoma
    • 12.4.5. Other Indications
  • 12.5. Market Value Forecast, by Sales Channel, 2023-2031
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Sales
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Indication
    • 12.7.3. By Sales Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Glaucoma Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2023-2031
    • 13.3.1. Prostaglandin Analogs (PGAs)
    • 13.3.2. Alpha Agonist
    • 13.3.3. Beta Blockers
    • 13.3.4. Cholinergic
    • 13.3.5. Carbonic Anhydrase Inhibitors
    • 13.3.6. Combined Medications
  • 13.4. Market Value Forecast, by Indication, 2023-2031
    • 13.4.1. Angle Closure Glaucoma (ACG)
    • 13.4.2. Open Angle Glaucoma (OAG)
    • 13.4.3. Secondary Glaucoma
    • 13.4.4. Congenital Glaucoma
    • 13.4.5. Other Indications
  • 13.5. Market Value Forecast, by Sales Channel, 2023-2031
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Sales
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Indication
    • 13.7.3. By Sales Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Glaucoma Treatment Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2023-2031
    • 14.3.1. Prostaglandin Analogs (PGAs)
    • 14.3.2. Alpha Agonist
    • 14.3.3. Beta Blockers
    • 14.3.4. Cholinergic
    • 14.3.5. Carbonic Anhydrase Inhibitors
    • 14.3.6. Combined Medications
  • 14.4. Market Value Forecast, by Indication, 2023-2031
    • 14.4.1. Angle Closure Glaucoma (ACG)
    • 14.4.2. Open Angle Glaucoma (OAG)
    • 14.4.3. Secondary Glaucoma
    • 14.4.4. Congenital Glaucoma
    • 14.4.5. Other Indications
  • 14.5. Market Value Forecast, by Sales Channel, 2023-2031
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Sales
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Indication
    • 14.7.3. By Sales Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Novartis AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Pfizer, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Merck & Co., Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Bausch & Lomb Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Allergan Plc
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Perrigo Plc
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Akorn, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Mobius Therapeutics, LLC
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 02: Global Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 03: Global Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031
  • Table 04: Global Glaucoma Treatment Market Size (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 07: North America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 08: North America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031
  • Table 09: Europe Glaucoma Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 11: Europe Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 12: Europe Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031
  • Table 13: Asia Pacific Glaucoma Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 15: Asia Pacific Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 16: Asia Pacific Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031
  • Table 17: Latin America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 19: Latin America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 20: Latin America Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031
  • Table 21: Middle East & Africa Glaucoma Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Glaucoma Treatment Market Size (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 23: Middle East & Africa Glaucoma Treatment Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 24: Middle East & Africa Glaucoma Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2023-2031

List of Figures

  • Figure 01: Global Glaucoma Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031
  • Figure 02: Global Glaucoma Treatment Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Global Glaucoma Treatment Market Value Share, by Product Type, 2022
  • Figure 04: Global Glaucoma Treatment Market Revenue (US$ Mn), by Indication, 2022
  • Figure 05: Global Glaucoma Treatment Market Value Share, by Indication, 2022
  • Figure 06: Global Glaucoma Treatment Market Revenue (US$ Mn), by Sales Channel, 2022
  • Figure 07: Global Glaucoma Treatment Market Value Share, by Sales Channel, 2022
  • Figure 08: Global Glaucoma Treatment Market Value Share, by Region, 2022
  • Figure 09: Global Glaucoma Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 11: Global Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 12: Global Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 13: Global Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 14: Global Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 15: Global Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031
  • Figure 16: Global Glaucoma Treatment Market Value Share Analysis, by Region, 2023 and 2031
  • Figure 17: Global Glaucoma Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Glaucoma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 19: North America Glaucoma Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Glaucoma Treatment Market Value Share Analysis, by Country, 2023 and 2031
  • Figure 21: North America Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 22: North America Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 23: North America Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 24: North America Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 25: North America Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 26:North America Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031
  • Figure 27: Europe Glaucoma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 28: Europe Glaucoma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Glaucoma Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 30: Europe Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 31: Europe Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 32: Europe Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 33: Europe Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 34: Europe Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 35: Europe Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031
  • Figure 36: Asia Pacific Glaucoma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 37: Asia Pacific Glaucoma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Glaucoma Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 39: Asia Pacific Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 40: Asia Pacific Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 41: Asia Pacific Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 42: Asia Pacific Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 43: Asia Pacific Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 44: Asia Pacific Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031
  • Figure 45: Latin America Glaucoma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 46: Latin America Glaucoma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Glaucoma Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 48: Latin America Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 49: Latin America Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 50: Latin America Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 51: Latin America Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 52: Latin America Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 53: Latin America Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031
  • Figure 54: Middle East & Africa Glaucoma Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 55: Middle East & Africa Glaucoma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Glaucoma Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 57: Middle East & Africa Glaucoma Treatment Market Value Share Analysis, by Product Type, 2023 and 2031
  • Figure 58: Middle East & Africa Glaucoma Treatment Market Value Share Analysis, by Indication, 2023 and 2031
  • Figure 59: Middle East & Africa Glaucoma Treatment Market Value Share Analysis, by Sales Channel, 2023 and 2031
  • Figure 60: Middle East & Africa Glaucoma Treatment Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Middle East & Africa Glaucoma Treatment Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 62: Middle East & Africa Glaucoma Treatment Market Attractiveness Analysis, by Sales Channel, 2023-2031